These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7466558)

  • 1. [Unfavourable effects of platelet transfusions (author's transl)].
    Gelabert A; Puig L; Arriaga F; Ercilla G; Casals F; Mazzara R; Calvo M; Grañena A; Vives J; Castillo R
    Sangre (Barc); 1980; 25(5B):799-806. PubMed ID: 7466558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unfavourable reactions to leucocyte transfusions (author's transl)].
    Montoro JA; González MA; Soler MA; Pérez Castellanos T; Carbonell F; Rodríguez R; Chacón C; Puig N; Marty ML
    Sangre (Barc); 1980; 25(5B):785-98. PubMed ID: 7466557
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors affecting the results of platelet transfusions (author's transl)].
    Harada K; Adachi M
    Rinsho Ketsueki; 1977 May; 18(5):596-601. PubMed ID: 904080
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors influencing transfused platelet recovery and survival, especially antiplatelet antibody (author's transl)].
    Shimoyama M; Ohkura H; Minato K; Inoue K; Takenaka T
    Rinsho Ketsueki; 1977 Jul; 18(7):868-75. PubMed ID: 916216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Development of lymphocytotoxic antibody and antiplatelet antibody following blood transfusion and their clinical significance in platelet transfusion (author's transpl)].
    Deura K; Shimoyama M; Minato K; Kimura K; Shibata Y; Juji T
    Rinsho Ketsueki; 1978 Apr; 19(4):323-30. PubMed ID: 702815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute graft-versus-host disease in a patient with acute myeloblastic leukemia following consolidation therapy and platelet transfusions].
    Takanashi M; Masuda M; Motoji T; Oshimi K; Mizoguchi H; Osada K; Shimizu M; Mori S
    Rinsho Ketsueki; 1988 Nov; 29(11):2136-40. PubMed ID: 3236422
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet and granulocyte transfusion and HLA (author's transl)].
    Juji T
    Rinsho Byori; 1978 Oct; 26(10):856-60. PubMed ID: 713087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy with blood components (author's transl)].
    Woitinas F; Dietzfelbinger H
    MMW Munch Med Wochenschr; 1981 Feb; 123(6):211-5. PubMed ID: 6782463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated immune modulation: a reason to TRIM platelet transfusions?
    Geiger TL
    Transfusion; 2008 Sep; 48(9):1772-3. PubMed ID: 18811896
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hazards of acute and chronic massive transfusions (author's transl)].
    Barbolla L; Regidor MC; Sanjuán I; Zabala P; Cabrera R; Fernández MN
    Sangre (Barc); 1980; 25(5B):828-47. PubMed ID: 7466560
    [No Abstract]   [Full Text] [Related]  

  • 11. [The possibility of blood component therapy in Croatia (author's transl)].
    Grgicević D; Bozović I; Pende B
    Lijec Vjesn; 1981; 103(2-3):119-22. PubMed ID: 7311696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood component therapy. Supportive therapy for acute leukemia (author's transl)].
    Maekawa I; Sakurada K; Shiraishi T
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):381-6. PubMed ID: 336501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood transfusions in the course of anaesthesia and professional accuracy (author's transl)].
    Schmidt W
    Zentralbl Chir; 1977; 102(17):1071-3. PubMed ID: 919849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aplastic anemia with antiplatelet iso-antibody and intracerebral hemorrhage--a case report of a child treated by platelet transfusion, splenectomy and craniotomy (author's transl)].
    Fukazawa K; Nagao T; Kuwana N; Pak S; Juji T; Shibata Y
    Rinsho Ketsueki; 1980 Nov; 21(11):1761-6. PubMed ID: 7206230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fractionated transfusions and leukapheresis: Their application and problems in the therapy of leukemia. Platelet transfusion. a. Methods and efficacies (author's transl)].
    Iwanaga T; Amemiya Y
    Rinsho Ketsueki; 1977 May; 18(5):587-95. PubMed ID: 904079
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of definitions and mechanisms of refractoriness to platelet transfusions.
    Hester JP; Ventura GJ
    Prog Clin Biol Res; 1990; 337():49-58. PubMed ID: 2191338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of microaggregation in stored blood (author's transl)].
    Harke H
    Anaesthesist; 1976 Aug; 25(8):374-9. PubMed ID: 1085108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transfusion reactions.
    Shafer N; Wilkenfeld M; Shafer R
    Leg Med; 1980; ():207-20. PubMed ID: 7421388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attempted clearance by massive plasmapheresis of an anti-HLA antibody in a patient who had received multiple transfusions (author's transl)].
    Sebahoun G; Lefevre P; Carcassonne Y; Battaglini P
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2483. PubMed ID: 693295
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of erythroleukemia with marker chromosome, terminating in acute myeloblastic leukemia after blood transfusions (author's transl)].
    Nakano Y; Sampi K; Gocho Y; Katayama S; Urushizaki I
    Rinsho Ketsueki; 1973 Nov; 14(11):1102-8. PubMed ID: 4522127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.